Showing results (221-230 of 241) with videos related to
Sort By:
Pageof 25
Journal of Biological Standardization|July 1, 1985
A collaborative study of a preparation of normal human serum for use as a reference in the assay of beta 2 microglobulinC Vincent, J Esteve, E H Cooper, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1989
Neuron-specific enolase can be used as the sole guide to treat small-cell lung cancer patients in common clinical practiceT A Splinter, D N Carney, M Teeling, et al.British Journal of Cancer|May 1, 1993
The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancerU Ward, J N Primrose, P J Finan, et al.British Journal of Urology|December 1, 1986
Biochemical monitoring of carcinoma of prostate treated with an LH-RH analogue (Zoladex)J K Siddall, J W Hetherington, E H Cooper, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|October 31, 1985
An enzyme-amplified monoclonal immunoenzymometric assay for prostatic acid phosphataseD W Moss, C H Self, K B Whitaker, et al.Electrophoresis|May 27, 1999
The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis--preliminary findingsR E Banks, M J Dunn, M A Forbes, et al.British Journal of Cancer|June 1, 1993
Clinical evaluation of serum tumour marker CA 242 in non-small cell lung cancerJ L Pujol, E H Cooper, M Lehmann, et al.British Journal of Urology|December 1, 1988
TNM classification of genitourinary tumours 1987--position of the EORTC Genitourinary GroupF H Schröder, E H Cooper, F M Debruyne, et al.Pediatric Surgery International|July 7, 2023
Incidence of medullary thyroid carcinoma and Hirschsprung disease based on the cosmos databaseL A Wehrli, M L Reppucci, J Ketzer, et al.Cancer|September 1, 1990
Prostatic specific antigen and the prediction of prognosis in metastatic prostatic cancerE H Cooper, T G Armitage, M R Robinson, et al.Pageof 25